Author: Weinstock-Guttman B. Jacobs L.D.
Publisher: Adis International
ISSN: 0012-6667
Source: Drugs, Vol.59, Iss.3, 2000-03, pp. : 401-410
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Adalimumab: Optic neuritis and multiple sclerosis?: case report
Reactions Weekly, Vol. 1, Iss. 1334, 2011-01 ,pp. :
Infliximab: Multiple sclerosis?: case report
Reactions Weekly, Vol. 1, Iss. 1361, 2011-01 ,pp. :
Simvastatin: beneficial effects in multiple sclerosis?
Inpharma, Vol. 1, Iss. 1438, 2004-01 ,pp. :
Early-Stage Multiple Sclerosis: What Are the Treatment Options?
Drugs, Vol. 64, Iss. 18, 2004-01 ,pp. :
Disease Modifying Treatments for Multiple Sclerosis: What is on the Horizon?
CNS Drugs, Vol. 11, Iss. 2, 1999-02 ,pp. :